Purpose: To provide updated summary information about antibacterial dental materials, primarily covering the literature from 2012 through 2017.
Methods: A key-worded search was conducted of peer-reviewed literature (Titles/Abstracts) indexed by PubMed databases, constrained to "English" and " dental" publications between the years 2012 and 2017. Key words applied to the search included: antimicrobial, antibacterial, primer, bonding agent, adhesive, cement, composite, liner, sealant, etchant, and core-build-up. Titles and abstracts of the articles returned by the search were reviewed and evaluated for appropriateness for inclusion in this review.
Results: A variety of antibacterial agents have been incorporated into experimental and commercial dental restorative materials to provide antibacterial activity in dental applications. No new antibacterial compounds were introduced in this review period (2012-2017), since the last review of period of 1980-2012. Antibacterial agents include leachable compounds (e.g. benzalkonium chloride, chlorhexidine), polymerizable monomers (e.g. quaternary ammonium methacrylates), and filler particles (e.g. silver nanoparticle). During the 2012-2017 review period, many antibacterial agents were tested in experimental formulations, but only four agents (benzalkonium chloride, chlorhexidine, glutaraldehyde, and MDPB) were used in commercial products.
Clinical Significance: Leachable antibacterial agents are the most frequently used type of antibacterial dental materials, but their efficacy may be short-lived due to their characteristic burst effect. Solid filler particles appear to be effective antibacterial agents, especially given their ability to reduce biofilm formation, but the color stability of their component metal particles is unfavorable for use in a commercial product. Polymerizable antibacterial agents (MDPB) are theoretically a good choice of material because they are very effective at killing any residual bacteria in a cavity preparation prior to polymerization, however, apart from their proven effect on reduction of biofilm formation, their long-term clinical performance is still questionable.
Download full-text PDF |
Source |
---|
Br J Hosp Med (Lond)
January 2025
Department of Rheumatism and Immunity, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Patients receiving kidney transplant experience immunosuppression, which increases the risk of bacterial, viral, fungal, and parasitic infections. Q fever is a potentially fatal infectious disease that affects immunocompromised renal transplant recipients and has implications in terms of severe consequences for the donor's kidney. A patient with acute Q fever infection following kidney transplantation was admitted to the Tsinghua Changgung Hospital in Beijing, China, in March 2021.
View Article and Find Full Text PDFBr J Hosp Med (Lond)
January 2025
Department of Pediatrics, Huoqiu First People's Hospital, Lu'an, Anhui, China.
Lobar pneumonia is an acute inflammation with increasing incidence globally. Delayed treatment can lead to severe complications, posing life-threatening risks. Thus, it is crucial to determine effective treatment methods to improve the prognosis of children with lobar pneumonia.
View Article and Find Full Text PDFLuminescence
January 2025
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
The environmental impact of chemicals used in aquaculture, particularly nitrofurantoin, has raised global concern. Nitrofurantoin, a broad-spectrum antimicrobial, is commonly used in aquaculture despite safety risks. Determination of nitrofurantoin in water samples of fish ponds is necessary to ensure the safety and quality of seafood.
View Article and Find Full Text PDFViruses
January 2025
College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Background: HIV and tuberculosis (TB) co-infection poses a significant health challenge, particularly when involving the central nervous system (CNS), where it leads to severe morbidity and mortality. Current treatments face challenges such as drug resistance, immune reconstitution inflammatory syndrome (IRIS), and persistent inflammation. Glutathione (GSH) has the therapeutic potential to enhance treatment outcomes by improving antibiotic efficacy, reducing inflammation, and mitigating immune dysfunction.
View Article and Find Full Text PDFViruses
January 2025
Service des Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière, APHP Sorbonne Université, 75013 Paris, France.
Phage therapy is experiencing renewed interest, particularly for antibiotic-resistant infections, and may also be useful for difficult-to-treat cases where surgery to remove foreign infected material is deemed too risky. We report a case of recurrent endocarditis with Bentall infection treated successfully with a combination of antibiotics and phages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!